S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Home
Investing
Stocks
USA
NASDAQ
Net Servicos DE Comunicacao S.A. ADS (MM) (NETCD)
Net Servicos DE Comunicacao S.A. ADS (MM) (NETCD) News

Net Servicos DE Comunicacao S.A. ADS (MM) (NETCD)

0.00

0.00

(0.00%)

Closed 13 July 6:00AM

0.00

0.00

(0.00%)

After Hours: -

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

0 articles were found

choo choo trader

choo choo trader 4 minutes ago

Thanks for reposting it Striper, somehow I missed it when gdog initially posted it. That is about the most informative video I have seen so far laying out the whole risk/reward story of $NLST.

ron_66271

ron_66271 5 minutes ago

No The FDIC and JPM both Had a Claim Against $24 Billion.

Inflated claim of $27*2=$54.00 Billion against the Estate to make WMI as insolvent for the Senior Note holders when JPM controlled the BK process because invested in the Senior Notes of WMI with the takeover.

skitahoe

skitahoe 5 minutes ago

Doc, I've been saying this for ages, but not that the full EDEN based facility must be completed. I believe the UK and other countries would simply like to know it's close. They'd like to know the EDEN is making commercial quality vaccine and that it can be delivered in quantity, and they'd like t

FDA-agent-2

FDA-agent-2 10 minutes ago

nobody is getting paid here .no editiing or no research which cost money.

Johnnycombat10

Johnnycombat10 10 minutes ago

I see both sides of the debate . The company has every right to state their position just as you have your right to speak yours. But you have right to demand anything from anyone on this board. You have no rights other than the right to speak our mind. And I have the to tell you to pound salt. If I

AstroGuru64

AstroGuru64 11 minutes ago

The issue still lies with the Treasury Department.

FDA-agent-2

FDA-agent-2 14 minutes ago

too much fake news on facebook, yahoo,and youtube these. and tabloid news or censored news.
sites like google, yahoo. facebook cannot get the content for cheap anymore or they won't even license it to them, it used to be free or very cheap to promote their newsight but they don't nobody ever

Truthsocial

Truthsocial 17 minutes ago

Vivos Inc. received U.S. FDA approval for the Investigational Device Exemption (IDE) for RadioGel® on July 6, 2026, which permits the initiation of the first-in-human feasibility study at Mayo Clinic in Jacksonville, FL.

While the FDA IDE approval has been granted, the study protocol

gfp927z

gfp927z 17 minutes ago

New York Times - >>> In the fourth quarter of 2025, Berkshire Hathaway acquired about 5.1 million shares of The New York Times Company, taking a roughly 3% stake valued at $350–$352 million. This was the first time Berkshire had invested in a newspaper since selling off its holdings in 2020. The mov

uber darthium

uber darthium 18 minutes ago

DBSCAM’em

A Linda Poory SCAM for over 2 decades

Can’t wait to read that filing this week

Ought to make for some good SCAM reading

DBSCAM’em

Noted and Always Correct

zerosnoop

zerosnoop 18 minutes ago

All the GEMS & FACTS are in the latest 10Q filing. The PROVEN AOT is going GLOBAL.

We are now focusing on a potential sale of 150 units as an initial purchase order under the so-called Laksel LOI (discussed below). This represents a defined India focused initial program wit

gfp927z

gfp927z 20 minutes ago

New York Times - >>> In the fourth quarter of 2025, Berkshire Hathaway acquired about 5.1 million shares of The New York Times Company, taking a roughly 3% stake valued at $350–$352 million. This was the first time Berkshire had invested in a newspaper since selling off its holdings in 2020. The mov

raggi65

raggi65 20 minutes ago

Do you have a link to the discovery document filed by Quinn Emanuel?
825 pages – that sounds as though there might be plenty of useful arguments in there, and with a citable reference, they would be all the more compelling

juicyjuice10002

juicyjuice10002 23 minutes ago

Yes, Executive Order 14393 is widely expected to help Fannie Mae (FNMA) and Freddie Mac (FMCC) by laying the regulatory groundwork for their eventual exit from government conservatorship.

While much of the public text targets community banks, the order contains specific directives fo

chuck1418

chuck1418 27 minutes ago

volume is picking up and shares are turning over. this week could be a breakout if we can go and sustain doubles

DrivenByPain

DrivenByPain 28 minutes ago

$SNTX! LMMFAO! More Then Just Nice Volume Here My Boy .

RED44

RED44 32 minutes ago

Should have said accountant rather than auditor.

georgejjl

georgejjl 35 minutes ago

Alzheimer's Association International Conference®

July 12-15, 2026

Look at the 2026 Silver Sponsers

https://aaic.alz.org/role/sponsor.asp

Good luck and GOD bless,

mikepgator

mikepgator 39 minutes ago

https://x.com/pennystockluvr/status/2076479569289441491?s=46&t=MxR4z7pPou_0usGfqAHGvQ

bigtalan

bigtalan 41 minutes ago

Not sure if anyone has asked AI and then followed the rabbit hole but interest read
is there any current updates on any new research from RespireRx Pharmaceuticals IncRespireRx Pharmaceuticals Inc. is actively advancing two primary drug platforms. Recent updates include a U.S. Department of

COminer

COminer 44 minutes ago

I'd say we are, LOL

DrivenByPain

DrivenByPain 46 minutes ago

$SNTX🤑 Leal Be Pushing Out $200,000+ K / A Week Just For Payroll🤑

getsome140backagain

getsome140backagain 48 minutes ago

Filings usually happen mid month or end of month. Whether we have something or not here these seem to be dates to keep an eye out for in my opinion That is for substantial confirmation on what is going on. I am 100 percent on board for those that have come up with possible info that may precede thes

joe botts

joe botts 48 minutes ago

AND expect no bid!

Taleb Spinoza

Taleb Spinoza 48 minutes ago

Take a load off Fannie.https://youtu.be/FFqb1I-hiHE?is=4eZUbXt3GKUPqE3w

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN

Already have an account? Sign in

Don't have an account? Sign up

By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.